TAVR Advances, Medication Safety, and Diabetes Prevention Insights

In this episode, Dr. Chi-Ming Chow provides an in-depth overview of the PARTNER 2A trial, comparing Transcatheter Aortic Valve Replacement (TAVR) with Surgical Aortic Valve Replacement (SAVR), discussing the challenges, advancements, and outcomes in TAVR technology. He addresses medication management transformation, highlighting the complexities and errors in the refill process using the Swiss Cheese Model, and explores ways to reduce these errors through system improvements. The episode also examines long-term data from the Diabetes Prevention Program (DPP) trial, comparing lifestyle changes versus metformin in addressing multimorbidity and chronic conditions, and discusses the generalizability and benefits of DPP interventions.